In summary, this study combined data mining and network pharmacology approach to identify ten the CHs, fifteen major bioactive compounds (quercetin, wogonin, luteolin, etc.), and five key therapeutic targets (VEGF, CASP3, MYC, CYP1Y1, and NFKB1) in the treatment of CRC. This evidence concerns the gene VEGFA and colorectal carcinoma.